SCHEDULE 13G/A: LENSAR Inc. CEO Nicholas Curtis Discloses 8.5% Beneficial Ownership Stake
Beneficial Ownership Disclosure
Nicholas T. Curtis, Chief Executive Officer of LENSAR, Inc., has disclosed a beneficial ownership of 8.5% of the company's common stock as of March 31, 2025, totaling 1,023,482 shares.
Summary
- Nicholas T. Curtis, the Chief Executive Officer of LENSAR, Inc., is the beneficial owner of 1,023,482 shares of the company's common stock.
- This ownership represents 8.5% of the total outstanding common stock of LENSAR, Inc., based on 11,792,156 shares outstanding as of April 28, 2025.
- The beneficial ownership comprises 774,442 shares held of record, 231,190 shares underlying stock options exercisable within 60 days of March 31, 2025, and 17,850 shares underlying restricted stock units vesting within 60 days of March 31, 2025.
- Mr. Curtis holds sole voting and sole dispositive power over all 1,023,482 beneficially owned shares.
Sentiment
Score: 7
Explanation: The disclosure of a significant beneficial ownership by the CEO is generally positive as it aligns management's interests with shareholders. The filing itself is a routine regulatory update, which is neutral.
Positives
- The disclosure of a significant beneficial ownership stake (8.5%) by the Chief Executive Officer, Nicholas T. Curtis, indicates strong alignment of management's interests with those of shareholders.
- A substantial insider stake can signal confidence in the company's future prospects and performance.
Future Outlook
This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- Nicholas T. Curtis is identified as the Chief Executive Officer of LENSAR, Inc.
Industry Context
This filing is a routine regulatory disclosure of a significant insider ownership stake, common across all industries for publicly traded companies. It reflects an individual's investment position rather than operational or financial performance trends within the medical device or ophthalmology industry.
Comparison to Industry Standards
- An 8.5% beneficial ownership stake by a CEO is a substantial insider position, often viewed favorably by investors as it aligns the executive's financial interests directly with shareholder value creation.
- While specific comparable companies or projects are not mentioned, such a significant stake is generally higher than average for CEOs of similarly sized public companies, indicating a strong personal commitment to the company's success.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Nicholas T. Curtis | NA | Confirmation of existing role, not a change. |
Stakeholder Impact
- Shareholders: The significant beneficial ownership by the CEO can be seen as a positive signal, potentially increasing investor confidence due to strong alignment of interests between management and shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 04/28/2025 | Date as of which 11,792,156 shares of Common Stock were outstanding, used for percentage calculation. |
| 04/30/2025 | Date of filing of Issuer's Amendment No. 1 to its Annual Report on Form 10-K, disclosing shares outstanding. |
| 05/13/2025 | Signature date of the Schedule 13G filing by Nicholas T. Curtis. |
Keywords
LENSAR Inc., Nicholas T. Curtis, Beneficial Ownership, Common Stock, Insider Ownership, SEC Filing, Schedule 13G, Equity Stake, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.